Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Je-Tae Woo is active.

Publication


Featured researches published by Je-Tae Woo.


International Immunopharmacology | 2013

Nobiletin and tangeretin ameliorate scratching behavior in mice by inhibiting the action of histamine and the activation of NF-κB, AP-1 and p38

Se-Eun Jang; Kwon-Ryeol Ryu; Sung-Hwan Park; Suna Chung; Yuto Teruya; Myung Joo Han; Je-Tae Woo; Dong-Hyun Kim

Nobiletin and tangeretin are polymethoxy flavonoids that are abundantly present in the pericarp of Citrus unshiu (family Rutaceae) and the fruit of Citrus depressa (family Rutaceae). They exhibit various biological activities, including anti-inflammatory and anti-asthmatic effects. To evaluate the anti-allergic effects of nobiletin and tangeretin, we measured their inhibitory effects in histamine- or compound 48/80-induced scratching behavioral mice. Nobiletin and tangeretin potently inhibited scratching behavior, as well as histamine-induced vascular permeability. Furthermore, they inhibited the expression of the allergic cytokines, IL-4 and TNF-α as well as the activation of their transcription factors NF-κB, AP-1 and p38 in histamine-stimulated skin tissues. They also inhibited the expression of IL-4 and TNF-α and the activation of NF-κB and c-jun in PMA-stimulated RBL-2H3 cells. Furthermore, nobiletin and tangeretin inhibited protein kinase C (PKC) activity and the IgE-induced degranulation of RBL-2H3 cells. These agents showed potent anti-histamine effect through the Magnus test when guinea pig ileum was used. Based on these results, nobiletin and tangeretin may ameliorate scratching behavioral reactions by inhibiting the action of histamine as well as the activation of the transcription factors NF-κB and AP-1 via PKC.


Archive | 2010

Prophylactic and/or therapeutic agent for metabolic syndrome

Young-Sil Lee; Byung-Yoon Cha; xiao-xing Wang; Sun-Sil Choi; Bong-Keun Choi; Hiroshi Yamakawa; Kiyoto Saito; Takayuki Yonezawa; Toshiaki Teruya; Kazuo Nagai; Je-Tae Woo


Archive | 2007

Composition for preventing and/or treating bone disease, physiologically functional or health food containing thereof, and pharmaceutical containing thereof as active ingredients

Kun-Hyung Lee; Byung-Yoon Cha; Takayuki Yonezawa; Shin-ichi Hasegawa; Je-Tae Woo; Kazuo Nagai


Archive | 2013

Pharmaceutical Composition for Promoting Osteogenesis Containing Axial-equatorial Aryl-oriented Furofuran-type Lignan, and Pharmaceutical Preparation, Functional Food Product, and Health Food Product Comprising Composition

Midori Asai; Young-Sil Lee; Naomi Mase; Bong-Keun Choi; Byung-Yoon Cha; Takayuki Yonezawa; Toshiaki Teruya; Kazuo Nagai; Je-Tae Woo


Archive | 2007

Pharmaceutical composition for prevention and/or treatment of bone disease, functional food or health food comprising the composition, and pharmaceutical preparation comprising the composition as active ingredient

Takayuki Yonezawa; Hiroyuki Akazawa; Byung-Yoon Cha; Toshiaki Teruya; Je-Tae Woo; Masato Ohta


Archive | 2013

METHOD FOR MANUFACTURING SUBSTANCE CONTAINING NOBILETIN AND TANGERETIN DERIVED FROM CITRUS FRUITS, AND NOBILETIN- AND TANGERETIN-CONTAINING SUBSTANCE OBTAINED THEREBY

Toshiaki Teruya; Yuto Teruya; Saki Sugiyama; Je-Tae Woo


ics.org | 2016

Effects of nobiletin, a flavone from shekwasha (Citrrus depressa), on muscarinic receptors and voiding function in rats

Yoshihiko Ito; Mikina Matsui; Eriko Hikiyama; Eri Yoshikawa; Je-Tae Woo; Yuto Teruya; Tosiaki Teruya; Shizuo Yamada


Archive | 2015

Medicinal composition for preventing or improving dysuria, antagonist against dysuria-related receptor, and method for preventing or improving dysuria using medicinal composition or antagonist

伊藤 由彦; Yoshihiko Ito; 恵梨子 引山; Eriko Hikiyama; 静雄 山田; Shizuo Yamada; 済泰 禹; Je-Tae Woo; 勇人 照屋; Yuto Teruya; 公男 菅谷; Kimio Sugaya; さおり 西島; Saori Nishijima; 浩一 和久田; Hirokazu Wakuda; 和正 篠塚; Kazumasa Shinozuka


Archive | 2014

METHOD FOR PREVENTING AND/OR TREATING PERIODONTAL DISEASE

Je-Tae Woo; Masato Ohta; Takayuki Yonezawa; Toshiaki Teruya; Byung-Yoon Cha; Kazuo Nagai


Archive | 2013

SUGAR METABOLISM IMPROVING COMPOSITION, AND PHARMACEUTICAL PREPARATION CONTAINING SAID COMPOSITION

Takayuki Yonezawa; Je-Tae Woo; Kazumi Yagasaki

Collaboration


Dive into the Je-Tae Woo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Toshiaki Teruya

University of the Ryukyus

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge